Literature DB >> 6248853

Subclasses of external adenosine receptors.

C Londos, D M Cooper, J Wolff.   

Abstract

Cell surface adenosine receptors mediate either stimulation or inhibition of adenylate cyclase activity [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1], and the receptors that mediate these different responses can be discriminated with selected adenosine analogs. 5'-N-Ethylcarboxamide-adenosine is a more potent agonist at stimulatory receptors (Ra) than is N6-phenylisopropyladenosine, whereas the reverse potency order is seen with inhibitory receptors (Ri). The potency of adenosine is intermediate between the potencies of these two analogs. The relative potencies of adenosine receptor agonists are maintained in physiological responses in intact cells, such as steroidogenesis and inhibition of lipolysis. As with adrenergic receptors, subclasses of adenosine receptors differ functionally and pharmacologically.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6248853      PMCID: PMC349439          DOI: 10.1073/pnas.77.5.2551

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Effects of adenosine derivatives on cAMP accumulation and lipolysis in rat adipocytes and on adenylate cyclase in adipocyte plasma membranes.

Authors:  T Trost; K Stock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-08       Impact factor: 3.000

Review 2.  Role of adenine and guanine nucleotides in the activity and response of adenylate cyclase systems to hormones: evidence for multisite transition states.

Authors:  M Rodbell; M C Lin; Y Salomon; C Londos; J P Harwood; B R Martin; M Rendell; M Berman
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

3.  Adenosine as inhibitor of myocardial effects of catecholamines.

Authors:  J Schrader; G Baumann; E Gerlach
Journal:  Pflugers Arch       Date:  1977-11-25       Impact factor: 3.657

4.  Stimulatory and inhibitory effects of guanyl nucleotides on fat cell adenylate cyclase.

Authors:  J P Harwood; H Löw; M Rodbell
Journal:  J Biol Chem       Date:  1973-09-10       Impact factor: 5.157

5.  The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices.

Authors:  A Sattin; T W Rall
Journal:  Mol Pharmacol       Date:  1970-01       Impact factor: 4.436

6.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

7.  The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. I. Properties.

Authors:  S L Pohl; L Birnbaumer; M Rodbell
Journal:  J Biol Chem       Date:  1971-03-25       Impact factor: 5.157

8.  Activation of steroidogenesis and adenylate cyclase by adenosine in adrenal and Leydig tumor cells.

Authors:  J Wolff; G H Cook
Journal:  J Biol Chem       Date:  1977-01-25       Impact factor: 5.157

9.  Cardiovascular effects of nucleoside analogs.

Authors:  H H Stein; P Somani; R N Prasad
Journal:  Ann N Y Acad Sci       Date:  1975-08-08       Impact factor: 5.691

10.  5'-Guanylylimidodiphosphate, a potent activator of adenylate cyclase systems in eukaryotic cells.

Authors:  C Londos; Y Salomon; M C Lin; J P Harwood; M Schramm; J Wolff; M Rodbell
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

View more
  243 in total

Review 1.  A(2A) adenosine receptors in human peripheral blood cells.

Authors:  S Gessi; K Varani; S Merighi; E Ongini; P A Borea
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  Effects of A1 and A2 adenosine receptor antagonists on the induction and reversal of long-term potentiation in guinea pig hippocampal slices of CA1 neurons.

Authors:  S Fujii; H Kato; K Ito; S Itoh; Y Yamazaki; H Sasaki; Y Kuroda
Journal:  Cell Mol Neurobiol       Date:  2000-06       Impact factor: 5.046

3.  Effects of 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), a highly selective adenosine receptor antagonist, on force of contraction in guinea-pig atrial and ventricular cardiac preparations.

Authors:  H von der Leyen; W Schmitz; H Scholz; J Scholz; M J Lohse; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

4.  Effect of adenosine and adenosine analogs on [14C]aminopyrine accumulation by rabbit parietal cells.

Authors:  S Ota; H Hiraishi; A Terano; H Mutoh; Y Kurachi; T Shimada; K J Ivey; T Sugimoto
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

5.  Adenosine regulates the release of adrenocorticotropic hormone (ACTH) from cultured anterior pituitary cells.

Authors:  M B Anand-Srivastava; M Cantin; J Gutkowska
Journal:  Mol Cell Biochem       Date:  1989-08-15       Impact factor: 3.396

6.  Pentoxifylline modulation of plasma membrane functions in human polymorphonuclear leukocytes.

Authors:  W L Hand; M L Butera; N L King-Thompson; D L Hand
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

7.  Effects of adenosine analogues on contractile response and cAMP content in guinea-pig isolated ventricular myocytes.

Authors:  J Neumann; W Schmitz; H Scholz; B Stein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

8.  Characterization of the adenosine receptor mediating contraction in rat colonic muscularis mucosae.

Authors:  J J Reeves; J Coates; J E Jarvis; M J Sheehan; P Strong
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

9.  Inhibition of platelet aggregation by adenosine receptor agonists.

Authors:  G Cristalli; S Vittori; R D Thompson; W L Padgett; D Shi; J W Daly; R A Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

10.  Presynaptic adenosine A₁ receptors modulate excitatory transmission in the rat basolateral amygdala.

Authors:  Andrew R Rau; Olusegun J Ariwodola; Jeff L Weiner
Journal:  Neuropharmacology       Date:  2013-11-06       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.